# Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones"

> **NCT01945242** · — · COMPLETED · sponsor: **Takeda** · enrollment: 1374 (actual)

## Conditions studied

- Type 2 Diabetes Melitus

## Interventions

- **DRUG:** Alogliptin

## Key facts

- **NCT ID:** NCT01945242
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 1374 (ACTUAL)
- **Last updated:** 2016-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01945242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01945242, "Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones"". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01945242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*